• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Clinical significance of comprehensive expression analysis of cancer-related protein in non-small cell lung cancer using tissue microarray technology

Research Project

Project/Area Number 14571294
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Thoracic surgery
Research InstitutionAichi Cancer Center Research Institute

Principal Investigator

MITSUDOMI Tetsuya  Aichi Cancer Cener Res.Inst., Molecular Oncology, Researcher, 研究所・分子腫瘍学部, 研究員 (70209807)

Co-Investigator(Kenkyū-buntansha) YATABE Yasushi  Aichi Cancer Cener Res.Inst., Molecular Oncology, Researcher, 研究所・分子腫瘍学部, 研究員 (90280809)
Project Period (FY) 2002 – 2003
KeywordsNon-small cell lung cancer / tissue microarray oncogene / tumor suppressor gene / prognostic factor / TTF1 / maspin / 14-3-3sigma / 腫瘍抑制遺伝子
Research Abstract

First, we made TMA containing 976 cases of lung cancers and confirmed its validity by comparing the results obtained by the TMA with those by regular slides or mRNA expression experiments.
Using TMA from 241 lung cancer patients, we analyzed expression of p53, p27, RB, EGFR, Bcl2, Synaptophysin, CD56 and TTF1 for their potential prognostic implication. However, only TTF1 showed a marginal prognostic impact among these markers.
Thyroid transcription factor (TTF) 1 was expressed throughout the developmental stage of peripheral lung as well as 72% of pulmonary adenocarcinoma, suggesting that TTF1 could serve as a lineage marker of the peripheral lung. In contrast, expression of maspin, which is thought to be involved in motility or invasion of cancer cells, is inversely correlated with TTF1 expression, suggesting that this molecule is related to development of central airway.
14-3-3sigma expression was examined in a spectrum of neuroendocrine lung tumors. Most of the tumors belonging to all the four categories of neuroendocrine lung tumors (i.e., carcinoid, atypical carcinoid, neuroendocrine large cell carcinoma, small cell carcinoma) lost expression of 14-3-3sigma in neuroendocrine differentiation.
In summary, TMA allowed us rapid evaluation of expression of a given protein in many samples in the same experimental condition, which was very useful for analysis of molecular pathogenesis of lung cancer.

  • Research Products

    (61 results)

All Other

All Publications (61 results)

  • [Publications] Hamajima, N.: "NAD(P)H : quinone oxidoreductase 1 (NQO1) C6O9T polymorphism and the risk of eight cancers for Japanese"Int J Clin Oncol. 7. 103-108 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ichinose, Y: "A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology : the incidence of carcinomatous pleuritis after surgical intervention"J Thorac Cardiovasc Surg. 123. 695-699 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ito, H.: "A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung"J Epidemiol. 12. 258-265 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koshikawa, K: "Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo"Oncogene. 21. 2822-2838 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mitsudomi, T.: "Molecular lesions as targets for diagnosis and therapy of lung cancer"Gan To Kagaku Ryoho. 29 Suppl 1. 112-116 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mizuno, K.: "Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers"Oncogene. 21. 2328-2333 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yatabe, Y.: "TTF-1 expression in pulmonary adenocarcinomas"Am J Surg Pathol. 26. 767-773 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yatabe, Y.: "Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential"Oncogene. 21. 8310-8319 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Achiwa, H.: "Analysis of beta-tubulin gene alteration in human lung cancer cell lines"Cancer Lett. 201. 211-216 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Endoh, H.: "RASSE1A gene inactivation in non-small cell lung cancer and its clinical implication"Int J Cancer. 106. 45-51 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hanai, T.: "Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression"Cancer Sci. 94. 473-477 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiraki, A.: "Different risk relations with smoking for non-small-cell lung cancer : comparison of TP53 and TP73 genotypes"Asian Pac J Cancer Prev. 4. 107-112 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki, T.: "The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 is not related to the expression of EGFR or HER-2 or to K-ras gene status"Lung Cancer. 42. 35-41 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tajima, K.: "Expression of cancer/testis (CT) antigens in lung cancer"Lung Cancer. 42. 23-33 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamada, Y.: "Association of a polymorphism of the phospholipase D(2) gene with the prevalence of colorectal cancer"J Mol Med. 81. 126-131 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Endoh, H.: "Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative RT-PCR"J Clin Oncol. 22. 811-819 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ito, H.: "Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk"Carcinogenesis. (In press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koga, T.: "Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data"J Mol Diagn. 6. 90-95 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Osada, H.: "Reduced expression of class II HDAC genes are associated with poor prognosis in lung cancer"Int J Cancer. (In press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tajima, K.: "Interferon-gamma differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes"Int J Cancer. 110. 403-412 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tomida, S.: "Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients"Oncogene. (In press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yatabe, Y.: "Maspin expression in normal lung and non-small-cell lung cancers : cellular property-associated expression under the control of promoter DNA methylation"Oncogene. 23. 4041-4049 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yatabe, Y.: "CK2O expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas"J Pathol. 203. 645-652 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 光冨徹哉: "p53など分子マーカーの解析は臨床で意義があるか? 第17回肺癌学会ワークショップ記録集"肺癌. 42. 753-757 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 阿知和宏行: "抗癌剤感受性の予測"治療学. 36. 21-24 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 光冨徹哉: "肺癌の予後因子分子 マーカーを中心に"Medical Practice. 19. 14-20 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 光冨徹哉: "肺癌の診断 遺伝子診断"日本臨床. 60. 233-237 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 光冨徹哉: "われらがmolecular research 愛知県がんセンター 肺がん研究グループ"分子呼吸病. 420-421 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 光冨徹哉: "分子呼吸器病 ARCHIVES 肺がん"分子呼吸病. 6. 61-65 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 遠藤秀紀: "肺がんの分子マーカー"肺癌の臨床. 5. 135-140 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 国頭英夫: "座談会 分子標的治療の現状と未来"治療学. 36. 71-81 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水重喜: "肺癌の生物学 肺癌の分子病変"日本臨床. 60. 73-77 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 伊藤秀美: "肺癌にみられる遺伝子異常の遺伝疫学"現代医療. 35. 86-92 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 光冨徹哉: "肺がんの分子病態"がん分子標的治療. 1. 72-77 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 光冨徹哉: "遺伝子診断・予後因子"癌の臨床. 49. 1061-1070 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 堀尾芳嗣: "遺伝子治療"臨床医. 29. 501-503 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 遠藤秀紀: "癌の分子マーカーの意義"Mook肺癌の臨床2003. 231-238 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 柴田典子: "Macrodissectionを用いたp53遺伝子変異検出法の検討"医学検査. 52. 1425-1430 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hamajima, N: "NDA(P)H : quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese"Int Clin Oncol. 7. 103-108 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ichinose, Y.: "A prematurely terminated phase III trial of intraoerative intrapleural hypotonic cisplatin treatment in patients with resectednon-small cell lung cancer with postive pleural lavage cytology"j Thorac Cardiovasc Surg. 123. 695-699 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ito, H.: "A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the luna"J Epidemiol. 12. 258-265 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koshikawa, K.: "Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo"Oncogene. 21. 2822-2828 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mitsudomi, T.: "Molecular lesions as targets for diagnosis and therapy of lung cancer"Gan To Kagaku Ryoho. 29 Suppl 1. 112-116 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizuno, K.: "Aberrant typermethylation of the CHFR prophase checkpoint gene in human lung cancers"Oncogene. 21. 2328-2333 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yatabe, Y.: "Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential"Oncogene. 21. 8310-8319 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yatabe, Y.: "TTF-1 expression in pulmonary adenocarcinomas"Am J Surg Pathol. 26. 767-773 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Achiwa, H.: "Analysis of beta-tubulin gene alteration in human lung cancer cell lines"Cancer Lett. 201. 211-216 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Endoh, H.: "RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication"Int Cancer. 106. 45-51 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hanai, T.: "Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression"Cancer Sci. 94. 473-477 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hirai, A.: "Different risk relations with smoking for non-small-cell lung cancer : comparison of TP53 and TP73 genotypes"Asian Pac J Cancer Prev. 4. 107-112 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki, T.: "The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa'(1)) is not related to the expression of EGFR or HER-2 or to K-ras gene status"Lung Cancer. 42. 35-41 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tajima, K.: "Expression of cancer/testis (CT) antigens in lung cancer"Lung Cancer. 42. 23-33 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamada, Y.: "Association of a polymorphism of the phospholipase D(2) qene with the prevalence of colorectal cancer"J Mol Med. 81. 126-131 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Endoh, H.: "Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction"J Clin Oncol. 22. 811-819 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ito, H.: "Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg 399Gln, in Japanese lung cancer risk"Carcinogenesis. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koga, T.: "Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data"J Mol Diagn. 6. 90-95 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Osada, H.: "Reduced expression of class II HDAC genes are associated with poor prognosis in lung cancer"Int J Cancer. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tajima, K.: "Interferon-gamma differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes"Int J Cancer. 110. 403-412 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tomida, S.: "Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients"Oncogene. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yatabe, Y.: "Maspin expression in normal lung and non-small-cell lung cancers : cellular property-associated expression under the control of promoter DNA methylation"Oncogene. 23. 4041-4049 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yatabe, Y.: "CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in subset of lung adenocarcinomas"J Pathol. 203. 645-652 (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi